Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Number of Users by Therapeutic Area, Delivery Type, Application & Functionality The global patient engagement solutions market will witness a robust CAGR of 20.93%, valued at $13.42 billion in 2021, expected to appreciate and reach $74.28 billion by 2030, confirms Strategic Market Research. North America held the greatest revenue share in the industry, with 36.23% in 2021. Patient engagement refers to the involvement of healthcare professionals in the health and wellbeing of their patients. The patient data is stored in a patient engagement system and can be accessed by clinicians. Patient engagement platform is a tool which enables patients to communicate with their healthcare professionals through a mobile device, tablet, or computer. Patient engagement solution is recently becoming popular due to the rising cases of chronic diseases worldwide. According to the IDF (International Diabetes Federation), 537 million people aged between 20 to 79 years suffer from diabetes worldwide. The total number of diagnosed diabetes cases is expected to increase to 643 million by 2030 and 783 million by 2045. Patient Engagement Software can help reduce patients' absence for treatment by allowing them to consult virtually with doctors. The software enhances staff efficiency and productivity by automating certain tasks. The software increases the revenue for healthcare providers by engaging patients at various stages in treatment, billing, and scheduling. It decreases potential costs that the hospital could bear due to the absence of patients. Patient Engagement Software can enhance the adoption of patient portals. Due to the rising preference for this software, patient engagement solutions are increasingly being used in various medical institutions. According to DocASAP, over 50% of patients from all age groups preferred digital tools over the phone for appointment reminders and post-care communications, while according to Regenstrief Institute, 47% of the people are using technology to communicate effectively with their healthcare providers. Key Industry Drivers - Implementation of Government Initiatives and Regulations and Increasing Healthcare Expenditure to Promote Patient-centric Care, Prevalence of Chronic Diseases Governments throughout the world are implementing various policies and measures to encourage the use of patient engagement solutions. For example, in 2020, EU Health Ministers signed a declaration to collaborate and establish an eHealth common area to facilitate the movement of electronic health information across Europe. The declaration states that eHealth be incorporated into the Europe 2020 agenda. The increasing healthcare expenditure by various governments to promote patient-centred care has also increased the adoption of patient engagement software in various medical institutions. According to the ONS (Office for National Statistics), Government of the United Kingdom, the total current healthcare expenditure in the UK is estimated at GBP 277 billion, a 7.4% increase from GBP 256.5 billion spent in 2020. The continuous implementation of government initiatives and regulations and increased healthcare expenditure to promote patient-centred care help boost the patient engagement solutions market trends. Chronic illnesses and ailments are on the rising spree all over the world. An ageing population and changes in cultural behaviour contribute to a steady rise in these prevalent health issues. According to the CDC, the number of Americans suffering from atrial fibrillation (the most commonly diagnosed heart arrhythmia) ranges from 2.7 to 6.1 million. This number is expected to rise to 12.1 million Americans by 2030. The rising cases of chronic diseases increase the need for greater patient engagement, which drives the market growth. Restraints The increasing concerns about the security of patient health data are creating barriers in the data transfer across various stakeholders in the healthcare business. Due to this, patient engagement programmes in many healthcare institutions are being hampered, as is the acceptance of patient engagement solutions among prospective end users. Opportunities - Increasing Adoption of New Technology The growing adoption of new technology for better patient engagement could help boost the market growth while also lowering administrative costs. According to McKinsey, technologies that make it possible to deliver healthcare less expensively could save administrative costs up to USD 175 billion to USD 220 billion a year if they came to widespread use. The increased digitisation of certain healthcare tools like patient engagement services could reduce these costs by an additional USD 24 billion to USD 48 billion annually through productivity gains. New patient engagement tools like patient engagement tools, Off-the-shelf patient engagement solutions, CMS-based patient engagement solutions, Custom-built patient engagement solutions, Digital engagement solutions, Biometric authentication solutions, and Call deflection solutions can help in real-time patient engagement while helping the growth of the interactive industry and patient navigation market size. Market Analysis Of Different Segments Covered in the Report Based on Delivery Type On-Premise Web & Cloud-based Based on Component Software and Hardware Services Based on Functionality Communication Billing & Payments Health Tracking & Insights Administrative Patient Education Others Based on Therapeutic Area Chronic Disease Management Health & Wellness Others Based on Application Population Health Management Outpatient Health Management In-Patient Health Management Others Based on End-User Providers Payers Others Regional Coverage Analysis North America United States of America Canada Europe United Kingdom Germany France Spain Italy The Netherlands Russia Sweden Rest of Europe Asia-Pacific China India Japan Australia South Korea Australia Rest of Asia-Pacific LAMEA Mexico Brazil Argentina Saudi Arabia South Africa Israel United Arab Emirates Rest of LAMEA Segments Analysis & Insights The web and cloud-based category dominated the market with a more than 75% revenue share in 2021. The section is also expected to grow quickly over the projection period. The popularity of these solutions is growing due to remote access to real-time data tracking, ease of use, low handling costs, integrated features and simple and fast data backup. The software and hardware category held the greatest patient engagement solutions market share of more than 60% in 2021 and is poised to grow at the quickest CAGR during the forecast period. The solution’s core offering is patient engagement hardware and software. Because of straightforward user interfaces and continual product improvements, it is simple to install, utilise, and retrieve records. As the main offering of any patient engagement solution, the communication category accounted for the greatest revenue share of more than 35.0% in 2021. This substantial proportion may be ascribed to an increase in the demand for and implementation of mhealth, telehealth and other virtual communication solution via voice, video, and text. The COVID-19 pandemic has accelerated the already rapid adoption of virtual communication systems, which have broadened their use for mental health, remote patient monitoring and a variety of other modalities. According to McKinsey, in February 2021, the use of telehealth has been stabilised at a level which is 38 times higher than it was before the onset of the pandemic in February 2020 after witnessing a spike which was 80 times higher than before the pandemic in April 2020. This could lead to governments and private organizations spending more on virtual healthcare. Chronic disease management led the market in 2021, with more than 40% of total revenue. The rising senior population in key economies and the adoption of digital technology accelerated by the COVID-19 pandemic have all contributed to the segment’s substantial market share. According to Eurostat, more than one-fifth (20.8%) of the European population were aged 65 and over. The geriatric population share in Europe is expected to increase from 6% in 2021 to 14.6% in 2100. The rising cases of chronic diseases have also led to the segment’s growth. According to the International Diabetes Federation, 61 million Europeans are diagnosed with diabetes. The number of Europeans with diabetes is expected to increase to 67 million by 2030 and 69 million by 2045. In 2021, the outpatient health management segment led the patient engagement software market report with more than 35.0% of total revenue. Patients with chronic diseases must be checked and updated on managing their condition. Patients are becoming more active in their treatment planning, tracking, and optimisation. In 2021, providers had the highest revenue share, estimated at approximately 53%. Providers serve the greatest number of patients and are also the first line of treatment for general to specialty health conditions. As a result, these end users are most likely to employ patient engagement solutions. Because of significant players’ presence, increased use of mhealth and EHR, and big corporations’ expanding investments in patient engagement software, North America held the greatest revenue share of 36.23% in 2021. Furthermore, rising awareness and increased government investment in the healthcare sector will boost growth. The Deputy Prime Minister of Canada has stated that Canada has invested over CAD 63 billion to provide support to its citizens’ healthcare and an additional CAD 2 billion to reduce waiting times. The Asia Pacific market is destined to develop at a profitable rate of 18.8% during the forecast period. Growing internet and smartphone penetration, a huge patient population, improved healthcare infrastructure and service quality, and local players are some of the main drivers expected to give attractive development possibilities to the market throughout the projection period. The International Diabetes Federation, announced that, more than 141 million Chinese have diabetes, while 36 million Chinese under the age of 20 has Type 1 diabetes. According to a FICCI and BCG study, 535 million Indians have Dyslipidaemia, 250 million suffer from hypertension, and 76 million have Type 2 diabetes. This will further propel the growth of Patient Engagement Solution in the APAC region. Patient Engagement Solutions Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 11.10 billion The revenue forecast in 2030 USD 74.28 billion Growth rate CAGR of approximately 20.93% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Delivery Type, By Component, By Functionality, By Therapeutic Area, By Application, By End-User, and By Region By Delivery Type Web & Cloud-based, On-premise By Component Software and Hardware, Services By Functionality Health Tracking & Insights, Communication, Billing & Payments, Patient Education, Administrative, and Others By Therapeutic Area Health & Wellness, Chronic Disease Management, and Others By Application Outpatient Health Management, Population Health Management, In-Patient Health Management, and Others By End-User Payers, Providers, Others By Region Asia Pacific, North America, Europe, LAMEA Country Scope United States of America, Japan, United Kingdom, Germany, France, Spain, Italy, The Netherlands, Sweden, Russia, Canada, China, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Israel, United Arab Emirates Company Usability Profiles Cerner Corporation (a subsidiary of Oracle Corporation), NextGen Healthcare, Inc., Epic Systems Corporation, LLC, McKesson Corporation, Reed, Koninklijke Philips N.V., Experian Information Solution, Inc., athenahealth, Inc., Klara Technologies, Inc., IBM, Nuance Communications, Inc., Allscripts Healthcare, CPSI, Solutionreach, Inc., MEDHOST. Patient Engagement Solutions Market Competitive Landscape Analysis Because of the presence of big enterprises, the market for patient engagement solutions has been characterised by high competition. Key players control a significant portion of the market. Major companies plan to use new strategies such as regional penetration, mergers and acquisitions, new product/solution development, partnerships, and strategic collaborations to increase their market position. The major competitors in this market include: Cerner Corporation (a subsidiary of Oracle Corporation) MEDHOST Epic Systems Corporation Klara Technologies, Inc. Allscripts Healthcare, LLC McKesson Corporation Reed Koninklijke Philips N.V. Epic Systems Corporation IBM Experian Information Solution, Inc. athenahealth, Inc. Solutionreach, Inc. CPSI NextGen Healthcare, Inc Nuance Communications, Inc. Recent Developments On June 2022 WEBMD Health Corporation which is a market leader in health information services for consumers, healthcare professionals and physicians made an announcement that it has successfully acquired Mercury Healthcare which is a data analytics and a technology company. Mercury Healthcare that uses insights and data to assist healthcare organizations to build long lasting relationship with patients will successfully handhold WEBMD’s leading physician/consumer engagement and clinical education business. On July 2022 Biogen teamed with Happify Health to provide help and support to Multiple Sclerosis patients with the help of company’s AI- powered online care community Kopa. Biogen which is a major player in Multiple Sclerosis space will divulge educational content relate to its therapies for the Kota website and App with the primary aim to support individuals with Multiple Sclerosis through their entire care journey. On July 2022 Redi.Health which provides health management technology collaborated with Labcorp, a leading life sciences company. With the help of this joint effort Labcorp Drug Development patient access solution will successfully subsume the digital health support platform of Redi. Health to offer patients as well as their care providers a substantial variety of traditional and digital communication channels as well as tools which will have real time data sync facility that will further assist the patients in managing their health. In March 2022, UST announced the development of a first-of-its-kind digital engagement SaaS solution with Well-Beat. UST and Well-Beat believe that this new solution can deliver personalised and customised intervention by adapting dynamically to the behaviour of patients. The company also aims to decrease the burden on medical practitioners by implementing the software. In December 2021, Oracle Corporation announced the acquisition of Cerner Corporation for USD 28.3 billion. Cerner and Oracle believe that this acquisition can transform healthcare delivery by delivering better information to medical practitioners, making better treatment decisions, and improving patient outcomes. In March 2020, Get Real Health, a wholly-owned subsidiary of healthcare solution provider CPSI, introduced a new service called TalkWithYourDoc.com. The language-agnostic technology enables healthcare providers worldwide to continue providing revenue-generating services while meeting the requirements of patients during the transnational COVID 19 pandemic. In March 2020, Orion Health created the first complete pandemic outbreak monitoring system to relieve pressure on healthcare systems and limit the likelihood of the COVID-19 virus spreading further. The company’s existing and prospective clients will be able to use the Orion Health software at no cost. In November 2019, Birdeye announced its partnership with athenahealth, Inc. via the Marketplace programme. This newly integrated system is now accessible to athenahealth’s growing network of 160,000 healthcare providers as part of the athenahealth Marketplace to help them receive more online reviews, monitor patient feedback, and enhance the patient experience. Various Patient Engagement Software that Key Market Leaders Develop: Software Function Key Player Clinical Programs Solution Identify clinical treatment opportunities for diabetes, hypertension, smoking cessation, and other diseases McKesson Corporation HealtheLife: Engagement Maximize patient engagement and interaction by providing additional tools and opportunities for clinicians to understand their health. Cerner Corporation (a subsidiary of Oracle Corporation) NextGen Patient Engagement Solution Patient self-scheduling, virtual visits, and online payment options. NextGen Healthcare, Inc. MyChart Messaging doctors, attending e-visits, completing questionnaires, scheduling appointments. Epic Systems Corporation FollowMyHealth Customizable patient engagement platform. Allscripts Healthcare, LLC Frequently Asked Question About This Report What is the preferred method of patient engagement in healthcare? Outpatient method of Patient Engagement is the most preferred in healthcare. What is a patient engagement solution? The patient data is stored in a system and can be accessed by clinicians. The system is called a patient engagement solution. What are patient engagement platforms? A patient engagement platform is a tool that enables patients to communicate with their healthcare professionals through a mobile device, tablet, or computer. What is the meaning of patient engagement? Patient engagement refers to the involvement of healthcare professionals in the health and wellbeing of their patients. Which are the key factors driving the growth of the patient engagement solution market? Implementing government initiatives and regulations to promote patient-centred care and the prevalence of chronic diseases are the main drivers of the patient engagement solution market. Which region had the largest market size in the Patient Engagement Solution market? North America held the largest market share in the Patient Engagement Solution market. What is the growth of the patient engagement solution market? The patient engagement solution market is expected to grow at a CAGR of 20.93%. How big is the patient engagement solution market? The global patient engagement solutions market was valued at $11.10 Bn and is predicted to grow by a CAGR of 20.93% to reach $74.28 Bn by 2030. Sources https://idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html https://docasap.com/patient-access/9-patient-engagement-stats/ https://www.regenstrief.org/.well-known/captcha/?r=%2Farticle%2Fhalf-use-health-technology-to-communicate-with-health-providers%2F https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem/bulletins/ukhealthaccounts/2020 https://www.cdc.gov/heartdisease/atrial_fibrillation.htm https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/administrative-simplification-how-to-save-a-quarter-trillion-dollars-in-us-healthcare 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Patient Engagement Solution Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Patient Engagement Solution Market 4.2.1 market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 market, by region, 2021 - 2030 (USD Million) 4.4 By Delivery Type Business Analysis 4.4.1 market, By Delivery Type, 2021 - 2030 (USD Million) 4.5 By Application Business Analysis 4.5.1 market, By Application, 2021 - 2030 (USD Million) 4.6 Component Business Analysis 4.6.1 market, By Component, 2021 - 2030 (USD Million) 4.7 End-user Business Analysis 4.7.1 market, By End-user, 2021 - 2030 (USD Million) 4.8 Functionality Analysis 4.8.1 market, By Functionality, 2021 - 2030 (USD Million) 4.9 Therapeutic Area Analysis 4.9.1 market, By Therapeutic Area, 2021 - 2030 (USD Million) 4.10 Value Chain Analysis 4.11 Market Variable Analysis 4.11.1 Market Drivers Analysis 4.11.2 Market Restraints Analysis 4.12 Business Environment Analysis Tool 4.12.1 market PEST analysis 4.12.2 market Porter’s analysis 4.13 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. End-user Analysis 5.11.1. Trends in End-user (2014-2021) 5.11.2. Trends in End-user (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Delivery Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Delivery Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Web & Cloud-based 7.3.1. Web & Cloud-based market, 2021 - 2030 (USD Million) 7.4. On-premise 7.4.1. On-premise market, 2021 - 2030 (USD Million) 8. Market: By Application Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Population Health Management 8.3.1. Population Health Management market, 2021 - 2030 (USD Million) 8.4. Outpatient Health Management 8.4.1. Outpatient Health Management market, 2021 - 2030 (USD Million) 8.5. In-Patient Health Management 8.5.1. In-Patient Health Management market, 2021 - 2030 (USD Million) 8.6. Others 8.6.1. Others market, 2021 - 2030 (USD Million) 9. Market: By Component Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Software and Hardware 9.3.1. Software and Hardware market, 2021 - 2030 (USD Million) 9.4. Services 9.4.1. Services market, 2021 - 2030 (USD Million) 10. Market: By End-user Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Payers 10.3.1. Payers market, 2021 - 2030 (USD Million) 10.4. Providers 10.4.1. Providers market, 2021 - 2030 (USD Million) 10.5. Others 10.5.1. Others market, 2021 - 2030 (USD Million) 11. Market: By Functionality Segment Analysis 11.1. Introduction 11.2. Sales Volume & Revenue Analysis (2021-2030) 11.3. Communication 11.3.1. Communication market, 2021 - 2030 (USD Million) 11.4. Health Tracking & Insights 11.4.1. Health Tracking & Insights market, 2021 - 2030 (USD Million) 11.5. Billing & Payments 11.5.1. Billing & Payments market, 2021 - 2030 (USD Million) 11.6. Administrative 11.3.1. Administrative market, 2021 - 2030 (USD Million) 11.7. Patient Education 11.7.1. Patient Education market, 2021 - 2030 (USD Million) 11.8. Others 11.8.1. Others market, 2021 - 2030 (USD Million) 12. Market: By Therapeutic Area Segment Analysis 12.1. Introduction 12.2. Sales Volume & Revenue Analysis (2021-2030) 12.3. Health & Wellness 12.3.1. Health & Wellness market, 2021 - 2030 (USD Million) 12.4. Chronic Disease Management 12.4.1. Chronic Disease Management market, 2021 - 2030 (USD Million) 12.5. Others 12.5.1. Others market, 2021 - 2030 (USD Million) 13. Market: Regional Outlook 13.1 North America 13.1.1. North America market, By Delivery Type, 2021 - 2030 (USD Million) 13.1.2. North America market, By Application, 2021 - 2030 (USD Million) 13.1.3. North America market, by End-user, 2021 - 2030 (USD Million) 13.1.4. North America market, by Therapeutic Area, 2021 - 2030 (USD Million) 13.1.5. North America market, by Functionality, 2021 - 2030 (USD Million) 13.1.6. North America market, by Country, 2021 - 2030 (USD Million) 12.1.4.1. U.S. 12.1.4.1.1. U.S. market, By Delivery Type, 2021 - 2030 (USD Million) 12.1.4.1.2. U.S. market, By Application, 2021 - 2030 (USD Million) 12.1.4.1.3. U.S. market, by End-user, 2021 - 2030 (USD Million) 12.1.4.1.4. U.S. market, by Therapeutic Area, 2021 - 2030 (USD Million) 12.1.4.1.5. U.S. market, by Functionality, 2021 - 2030 (USD Million) 12.1.4.1.6. U.S. market, by Country, 2021 - 2030 (USD Million) 12.1.4.2. Canada 12.1.4.2.1. Canada market, By Delivery Type, 2021 - 2030 (USD Million) 12.1.4.2.2. Canada market, By Application, 2021 - 2030 (USD Million) 12.1.4.2.3. Canada market, by End-user, 2021 - 2030 (USD Million) 12.2. Europe 12.2.1. Europe market, By Delivery Type, 2021 - 2030 (USD Million) 12.2.2. Europe market, By Application, 2021 - 2030 (USD Million) 12.2.3. Europe market, by End-user, 2021 - 2030 (USD Million) 12.2.4. Europe market, by Therapeutic Area, 2021 - 2030 (USD Million) 12.2.5. Europe market, by Functionality, 2021 - 2030 (USD Million) 12.2.6. Europe market, by country, 2021 - 2030 (USD Million) 12.2.4.1 U.K. 12.2.4.1.1. U.K. market, By Delivery Type, 2021 - 2030 (USD Million) 12.2.4.1.2. U.K. market, By Application, 2021 - 2030 (USD Million) 12.2.4.1.3. U.K. market, by End-user, 2021 - 2030 (USD Million) 12.2.4.2. Germany 12.2.4.2.1. Germany market, By Delivery Type, 2021 - 2030 (USD Million) 12.2.4.2.2. Germany market, By Application, 2021 - 2030 (USD Million) 12.2.4.2.3. Germany market, by End-user, 2021 - 2030 (USD Million) 12.2.4.3. France 12.2.4.3.1. France market, By Delivery Type, 2021 - 2030 (USD Million) 12.2.4.3.2. France market, By Application, 2021 - 2030 (USD Million) 12.2.4.3.3. France market, by End-user, 2021 - 2030 (USD Million) 12.2.4.4. Rest of Europe 12.2.4.4.1. Rest of Europe market, By Delivery Type, 2021 - 2030 (USD Million) 12.2.4.4.2. Rest of Europe market, By Application, 2021 - 2030 (USD Million) 12.2.4.4.3. Rest of Europe market, by End-user, 2021 - 2030 (USD Million) 12.3. Asia Pacific 12.3.1. Asia Pacific market, By Delivery Type, 2021 - 2030 (USD Million) 12.3.2. Asia Pacific market, By Application, 2021 - 2030 (USD Million) 12.3.3. Asia Pacific market, by End-user, 2021 - 2030 (USD Million) 12.3.4. Asia Pacific market, by Therapeutic Area, 2021 - 2030 (USD Million) 12.3.5. Asia Pacific market, by Functionality, 2021 - 2030 (USD Million) 12.3.6. Asia Pacific market, by country, 2021 - 2030 (USD Million) 12.3.4.1. China 12.3.4.1.1. China market, By Delivery Type, 2021 - 2030 (USD Million) 12.3.4.1.2. China market, By Application, 2021 - 2030 (USD Million) 12.3.4.1.3. China market, by End-user, 2021 - 2030 (USD Million) 12.3.4.2. India 12.3.4.2.1. India market, By Delivery Type, 2021 - 2030 (USD Million) 12.3.4.2.2. India market, By Application, 2021 - 2030 (USD Million) 12.3.4.2.3. India market, by End-user, 2021 - 2030 (USD Million) 12.3.4.3. Japan 12.3.4.3.1. Japan market, By Delivery Type, 2021 - 2030 (USD Million) 12.3.4.3.2. Japan market, By Application, 2021 - 2030 (USD Million) 12.3.4.3.3. Japan market, by End-user, 2021 - 2030 (USD Million) 12.3.4.4. South Korea 12.3.4.4.1. South Korea market, By Delivery Type, 2021 - 2030 (USD Million) 12.3.4.4.2. South Korea market, By Application, 2021 - 2030 (USD Million) 12.3.4.4.3. South Korea market, by End-user, 2021 - 2030 (USD Million) 12.3.4.5. Rest of ASIA PACIFIC 12.3.4.5.1. Rest of ASIA PACIFIC market, By Delivery Type, 2021 - 2030 (USD Million) 12.3.4.5.2. Rest of ASIA PACIFIC market, By Application, 2021 - 2030 (USD Million) 12.3.4.5.3. Rest of ASIA PACIFIC market, by End-user, 2021 - 2030 (USD Million) 12.4. Latin America 12.4.1. Latin America market, By Delivery Type, 2021 - 2030 (USD Million) 12.4.2. Latin America market, By Application, 2021 - 2030 (USD Million) 12.4.3. Latin America market, by End-user, 2021 - 2030 (USD Million) 12.4.4. Latin America market, by Therapeutic Area, 2021 - 2030 (USD Million) 12.4.5. Latin America market, by Functionality, 2021 - 2030 (USD Million) 12.4.6. Latin America market, by Component, 2021 - 2030 (USD Million) 12.4.7. Latin America market, by country, 2021 - 2030 (USD Million) 12.4.4.1. Brazil 12.4.4.1.1. Brazil market, By Delivery Type, 2021 - 2030 (USD Million) 12.4.4.1.2. Brazil market, By Application, 2021 - 2030 (USD Million) 12.4.4.1.3. Brazil market, by End-user, 2021 - 2030 (USD Million) 12.4.4.2. Mexico 12.4.4.2.1. Mexico market, By Delivery Type, 2021 - 2030 (USD Million) 12.4.4.2.2. Mexico market, By Application, 2021 - 2030 (USD Million) 12.4.4.2.3. Mexico market, by End-user, 2021 - 2030 (USD Million) 12.4.4.3. Rest of the Latin America 12.4.4.3.1. Rest of the Latin America market, By Delivery Type, 2021 - 2030 (USD Million) 12.4.4.3.2. Rest of the Latin America market, By Application, 2021 - 2030 (USD Million) 12.4.4.3.3. Rest of the Latin America market, by End-user, 2021 - 2030 (USD Million) 12.5. MEA 12.5.1. MEA market, By Delivery Type, 2021 - 2030 (USD Million) 12.5.2. MEA market, By Application, 2021 - 2030 (USD Million) 12.5.3. MEA market, by End-user, 2021 - 2030 (USD Million) 12.5.4. MEA market, by Component, 2021 - 2030 (USD Million) 12.5.4. MEA market, by Therapeutic Area, 2021 - 2030 (USD Million) 12.5.4. MEA market, by Region, 2021 - 2030 (USD Million) 13. Competitive Landscape 13.1 Cerner Corporation 13.1.1. Company overview 13.1.2. Financial performance 13.1.3. Delivery Type Portfolio Analysis 13.1.4. Business Strategy & Recent Development 13.2. NextGen Healthcare, Inc 13.2.1. Company overview 13.2.2. Financial performance 13.2.3. Delivery Type Portfolio Analysis 13.2.4. Business Strategy & Recent Development 13.3. EPIC SYSTEMS CORPORATION 13.3.1. Company overview 13.3.2. Financial performance 13.3.3. Delivery Type Portfolio Analysis 13.3.4. Business Strategy & Recent Development 13.4. Allscripts Healthcare, LLC 13.4.1. Company overview 13.4.2. Financial performance 13.4.3. Delivery Type Portfolio Analysis 13.4.4. Business Strategy & Recent Development 13.5. McKesson Corporation 13.5.1. Company overview 13.5.2. Financial performance 13.5.3. Delivery Type Portfolio Analysis 13.5.4. Business Strategy & Recent Development 13.6. Reed 13.6.1. Company overview 13.6.2. Financial performance 13.6.3. Delivery Type Portfolio Analysis 13.6.4. Business Strategy & Recent Development 13.7. Koninklijke Philips N.V. 13.7.1. Company overview 13.7.2. Financial performance 13.7.3. Delivery Type Portfolio Analysis 13.7.4. Business Strategy & Recent Development 13.8. Klara Technologies, Inc 13.8.1. Company overview 13.8.2. Financial performance 13.8.3. Delivery Type Portfolio Analysis 13.8.4. Business Strategy & Recent Development 13.9. CPSI 13.9.1. Company overview 13.9.2. Financial performance 13.9.3. Delivery Type Portfolio Analysis 13.9.4. Business Strategy & Recent Development 13.10. Experian Information Solution, Inc 13.10.1. Company overview 13.10.2. Financial performance 13.10.3. Delivery Type Portfolio Analysis 13.10.4. Business Strategy & Recent Development 13.11. Athenahealth, Inc 13.11.1. Company overview 13.11.2. Financial performance 13.11.3. Delivery Type Portfolio Analysis 13.11.4. Business Strategy & Recent Development 13.12. Solutionreach, Inc 13.12.1. Company overview 13.12.2. Financial performance 13.12.3. Delivery Type Portfolio Analysis 13.12.4. Business Strategy & Recent Development 13.13. IBM 13.13.1. Company overview 13.13.2. Financial performance 13.13.3. Delivery Type Portfolio Analysis 13.13.4. Business Strategy & Recent Development 13.14. MEDHOST 13.14.1. Company overview 13.14.2. Financial performance 13.14.3. Delivery Type Portfolio Analysis 13.14.4. Business Strategy & Recent Development 13.15. Nuance Communications, Inc 13.15.1. Company overview 13.15.2. Financial performance 13.15.3. Delivery Type Portfolio Analysis 13.15.4. Business Strategy & Recent Development List of Tables (86 Tables) TABLE 1. MARKET, By Delivery Type, 2021-2030 (USD Million) TABLE 2. MARKET FOR Web & Cloud-based, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR On-premise, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET, By Application, 2021-2030 (USD Million) TABLE 5. MARKET FOR Population Health Management, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR Outpatient Health Management, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR In-Patient Health Management, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 10. MARKET FOR Payers, BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET FOR Providers, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET, By Component, 2021-2030 (USD Million) TABLE 14. MARKET FOR Software and Hardware, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Services, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET, By Functionality, 2021-2030 (USD Million) TABLE 17. MARKET FOR Communication, BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET FOR Health Tracking & Insights, BY REGION, 2021-2030 (USD Million) TABLE 19. MARKET FOR Billing & Payments, BY REGION, 2021-2030 (USD Million) TABLE 20. MARKET FOR Administrative, BY REGION, 2021-2030 (USD Million) TABLE 21. MARKET FOR Patient Education, BY REGION, 2021-2030 (USD Million) TABLE 22. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 23. MARKET, By Therapeutic Area, 2021-2030 (USD Million) TABLE 24. MARKET FOR Health & Wellness, BY REGION, 2021-2030 (USD Million) TABLE 25. MARKET FOR Chronic Disease Management, BY REGION, 2021-2030 (USD Million) TABLE 26. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 27. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 28. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 29. NORTH AMERICA MARKET, By Delivery Type, 2021-2030 (USD Million) TABLE 30. NORTH AMERICA MARKET, By Application, 2021-2030 (USD Million) TABLE 31. NORTH AMERICA MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 32. NORTH AMERICA MARKET, BY Therapeutic Area, 2021-2030 (USD Million) TABLE 33. NORTH AMERICA MARKET, BY Functionality, 2021-2030 (USD Million) TABLE 34. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 35. EUROPE MARKET, By Delivery Type, 2021-2030 (USD Million) TABLE 36. EUROPE MARKET, By Application, 2021-2030 (USD Million) TABLE 37. EUROPE MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 38. EUROPE MARKET, BY Therapeutic Area, 2021-2030 (USD Million) TABLE 39. EUROPE MARKET, BY Functionality, 2021-2030 (USD Million) TABLE 40. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 41. ASIA-PACIFIC MARKET, By Delivery Type, 2021-2030 (USD Million) TABLE 42. ASIA-PACIFIC MARKET, By Application, 2021-2030 (USD Million) TABLE 43. ASIA-PACIFIC MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 44. ASIA-PACIFIC MARKET, BY Therapeutic Area, 2021-2030 (USD Million) TABLE 45. ASIA-PACIFIC MARKET, BY Functionality, 2021-2030 (USD Million) TABLE 46. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 47. LAMEA MARKET, By Delivery Type, 2021-2030 (USD Million) TABLE 48. LAMEA MARKET, By Component, 2021-2030 (USD Million) TABLE 49. LAMEA MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 50. LAMEA MARKET, BY Therapeutic Area, 2021-2030 (USD Million) TABLE 51. LAMEA MARKET, BY Functionality, 2021-2030 (USD Million) TABLE 52. Cerner Corporation: COMPANY SNAPSHOT TABLE 53. Cerner Corporation: OPERATING SEGMENTS TABLE 54. NextGen Healthcare, Inc: COMPANY SNAPSHOT TABLE 55. NextGen Healthcare, Inc: OPERATING SEGMENTS TABLE 56. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT TABLE 57. EPIC SYSTEMS CORPORATION: OPERATING SEGMENTS TABLE 58. Allscripts Healthcare, LLC: COMPANY SNAPSHOT TABLE 59. Allscripts Healthcare, LLC: OPERATING SEGMENTS TABLE 60. McKesson Corporation: COMPANY SNAPSHOT TABLE 61. McKesson Corporation: OPERATING SEGMENTS TABLE 62. Reed: COMPANY SNAPSHOT TABLE 63. Reed: OPERATING SEGMENTS TABLE 64. Koninklijke Philips N.V.: COMPANY SNAPSHOT TABLE 65. Koninklijke Philips N.V.: OPERATING SEGMENTS TABLE 66. Klara Technologies, Inc: COMPANY SNAPSHOT TABLE 67. Klara Technologies, Inc: OPERATING SEGMENTS TABLE 68. CPSI: COMPANY SNAPSHOT TABLE 69. CPSI: OPERATING SEGMENTS TABLE 70. Experian Information Solution, Inc: COMPANY SNAPSHOT TABLE 71. Experian Information Solution, Inc: OPERATING SEGMENTS TABLE 72. Athenahealth, Inc: COMPANY SNAPSHOT TABLE 73. Athenahealth, Inc: OPERATING SEGMENTS TABLE 74. Solutionreach, Inc: COMPANY SNAPSHOT TABLE 75. Solutionreach, Inc: OPERATING SEGMENTS TABLE 76. IBM: COMPANY SNAPSHOT TABLE 77. IBM: OPERATING SEGMENTS TABLE 78. MEDHOST: COMPANY SNAPSHOT TABLE 79. MEDHOST: OPERATING SEGMENTS TABLE 80. Nuance Communications, Inc: COMPANY SNAPSHOT TABLE 81. Nuance Communications, Inc: OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Delivery Type-Based Estimation Figure 6 Top 15 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2021 Figure 8 Import Data for Patient Engagement Solution Market, By Country, 2016–2021 (USD Thousand) Figure 9 Export Data for Patient Engagement Solution Market, By Country, 2016–2021 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By End-user, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Delivery Type, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By Functionality, 2019 vs. 2025 (USD Million) Figure 15 Market Share, By Component, 2019 vs. 2025 (USD Million) Figure 16 Market Share, By Therapeutic Area, 2019 vs. 2025 (USD Million) Figure 17 Geographical Snapshot of the Market Figure 18 Web & Cloud-based to Witness Higher CAGR in Market for Delivery Type Segment during Forecast Period. Figure 19 Payers to Witness Higher CAGR in Market for End-user Segment during Forecast Period. Figure 20 Software and Hardware to Witness Higher CAGR in Market for Component Segment during Forecast Period. Figure 21 Communication to Witness Higher CAGR in Market for Functionality Segment during Forecast Period. Figure 22 Chronic Disease Management to Witness Higher CAGR in Market for Therapeutic Area Segment during Forecast Period. Figure 23 Outpatient Health Management to Witness Higher CAGR in the Market for Application Segment during Forecast Period. Figure 24 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 25 Market: Drivers, Restraints, Opportunities, and Challenges Figure 26 North America: Market Snapshot Figure 27 Asia Pacific: Market Snapshot Figure 28 Vendor Dive: Evaluation Overview